Table 1.
Compounda | Calibration curveb | R2 | Linear range (μg) | LOD (μg) | LOQ (μg) |
---|---|---|---|---|---|
1 | Y = 804.7x −478.1 | 0.9988 | 0.30–20 | 0.16 | 0.34 |
2 | Y = 840.7x −448.7 | 0.9998 | 0.28–20 | 0.14 | 0.32 |
3 | Y = 828.7x −586.0 | 0.9931 | 0.38–20 | 0.22 | 0.48 |
4 | Y = 905.6x −497.4 | 0.9978 | 0.22–18 | 0.12 | 0.28 |
5 | Y = 818.8x −499.9 | 0.9999 | 0.28–20 | 0.18 | 0.46 |
6 | Y = 743.7x −637.3 | 0.9951 | 0.28–20 | 0.18 | 0.42 |
7 | Y = 475.8x −410.4 | 0.9973 | 0.54–20 | 0.36 | 0.76 |
8 | Y = 770.5x −721.1 | 0.9977 | 0.42–20 | 0.28 | 0.62 |
9 | Y = 945.4x −852.4 | 0.9944 | 0.24–18 | 0.16 | 0.36 |
10 | Y = 687.2x −674.3 | 0.9981 | 0.36–20 | 0.28 | 0.74 |
(1) deapi-platycoside E; (2) platycoside E; (3) deapi-platycodin D3; (4) platycodin D3; (5) deapi-platycodin D; (6) platycodin D; (7) polygalacin D; (8) 3″-O-acetyl polygalacin D; (9) platycodin A; and (10) 2″-O-acetyl polygalacin D.
Y: peak area; x: concentration (μg).